Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950103-20-022116
Filing Date
2020-11-13
Accepted
2020-11-13 08:03:23
Documents
5
Period of Report
2020-11-13

Document Format Files

Seq Description Document Type Size
1 FORM 6-K dp140745_6k.htm 6-K 13041
2 EXHIBIT 99.1 dp140745_ex9901.htm EX-99.1 264851
3 EXHIBIT 99.2 dp140745_ex9902.htm EX-99.2 121454
4 EXHIBIT 99.3 dp140745_ex9903.htm EX-99.3 111525
5 GRAPHIC image_001.jpg GRAPHIC 2324
  Complete submission text file 0000950103-20-022116.txt   515209
Mailing Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000
Business Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000 41 21 345 91 21
AC Immune SA (Filer) CIK: 0001651625 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37891 | Film No.: 201309207
SIC: 2834 Pharmaceutical Preparations